Sarcoma  >>  dordaviprone (ONC201)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dordaviprone (ONC201) / Chimerix
NCT04854044: ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma

Withdrawn
1b
0
US
Akt/ERK Inhibitor ONC201, ONC201, TIC10, Radiation Therapy, Cancer Radiotherapy, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Resection, Surgical Resection
Jonsson Comprehensive Cancer Center, National Cancer Institute (NCI), Oncoceutics, Inc., University of California, Los Angeles
Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma
07/25
07/26

Download Options